ALN-AGT01 RVR

DRUG2 trials

Sponsors

Alnylam Pharmaceuticals

Conditions

Healthy VolunteersHypertension

Phase 1

A Study to Evaluate ALN-AGT01 RVR in Adult Healthy Volunteers

CompletedNCT06675565

Alnylam PharmaceuticalsHealthy Volunteers

Start: 2024-11-05End: 2025-09-08Updated: 2025-09-19

Phase 2

A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran

RecruitingNCT07553442

Alnylam PharmaceuticalsHypertension

Start: 2026-04-27End: 2028-10-01Target: 93Updated: 2026-09-14